Levofloxacin Actavis (Levofloxacin Hemihydrate)

Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By blocking these targets, the drug prevents bacterial cells from multiplying, leading to rapid bactericidal activity against a broad range of Gram‑negative and Gram‑positive ocular pathogens.

The dosage and frequency of Levofloxacin Actavis are determined by the prescribing clinician based on the specific infection, severity, and patient factors. Healthcare professionals will provide exact instructions on how many drops to instill and how often they should be administered.

Safety data for ocular levofloxacin in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Levofloxacin Actavis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levofloxacin belongs to the fluoroquinolone class and offers broad‑spectrum coverage, including many Gram‑negative organisms, compared with older agents such as ciprofloxacin or newer options like moxifloxacin. Its high ocular penetration and once‑ or twice‑daily dosing can provide convenient regimens, though resistance patterns and patient tolerance should guide selection.

Store Levofloxacin Actavis at temperatures below 25 °C, in its original container, protected from moisture and direct light. Do not freeze the product. Keep the vial tightly sealed when not in use and discard any solution that appears discolored or contaminated.

Levofloxacin Actavis is applied topically to the eye as drops or via subconjunctival injection, as directed by the prescriber. The patient should wash their hands before use, avoid touching the tip of the container to the eye or any surface, and follow the prescribed dosing schedule.

Serious adverse events, although rare, include severe allergic reactions (anaphylaxis), Stevens‑Johnson syndrome or toxic epidermal necrolysis, worsening of corneal ulcers, tendon rupture, and QT‑interval prolongation that can lead to cardiac arrhythmias. Immediate medical attention is required if any of these symptoms develop.

Levofloxacin Actavis should be avoided in individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It is also contraindicated in patients with a history of tendon disorders related to fluoroquinolone use, and caution is advised for those with prolonged QT interval or significant cardiac disease.